--- title: "CHENGDA PHARMA was reduced by 860,000 shares by its major shareholder Qianhai Shengtai" type: "News" locale: "en" url: "https://longbridge.com/en/news/231511788.md" description: "According to the Zhitong Finance APP, CHENGDA PHARMA announced that its shareholder Qianhai Shengtai, holding more than 5% of the shares, will reduce its holdings by a total of 860,000 shares through block trading from March 6, 2025, to March 11, 2025, accounting for 0.57% of the total share capital after excluding shares repurchased by the company" datetime: "2025-03-12T09:50:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/231511788.md) - [en](https://longbridge.com/en/news/231511788.md) - [zh-HK](https://longbridge.com/zh-HK/news/231511788.md) generator: "portal-rs" --- # CHENGDA PHARMA was reduced by 860,000 shares by its major shareholder Qianhai Shengtai According to the Zhitong Finance APP, CHENGDA PHARMA (301201.SZ) announced that its shareholder Qianhai Shengtai, holding more than 5% of the shares, will reduce its holdings by a total of 860,000 shares through block trading from March 6, 2025, to March 11, 2025, accounting for 0.57% of the total share capital after excluding the shares repurchased by the company ### Related Stocks - [301201.CN](https://longbridge.com/en/quote/301201.CN.md) ## Related News & Research - [Haisco Enters Into Exclusive License Agreement With New US Venture Founded By Population Health Partners And ARCH Venture Partners](https://longbridge.com/en/news/296910145.md) - [Cattle Prices Struggle but Get Some Bullish USDA Data; Lean Hog Prices Mired at 12-Month Low](https://longbridge.com/en/news/296804867.md) - [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md) - [Ganfeng Lithium, Lithium Argentina sign deal to jointly develop Consolidated Project via Millennial JV](https://longbridge.com/en/news/296790149.md) - [McChip adopts semi-annual reporting, skips quarterly filings under Canadian exemption](https://longbridge.com/en/news/296901899.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**